130 related articles for article (PubMed ID: 37872023)
21. Clinical Effects of Portulaca Oleracea Seeds on Dyslipidemia in Obese Adolescents: a Triple-blinded Randomized Controlled Trial.
Sabzghabaee AM; Kelishadi R; Jelokhanian H; Asgary S; Ghannadi A; Badri S
Med Arch; 2014 Jun; 68(3):195-9. PubMed ID: 25568533
[TBL] [Abstract][Full Text] [Related]
22. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
23. Interventions for infantile seborrhoeic dermatitis (including cradle cap).
Victoire A; Magin P; Coughlan J; van Driel ML
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011380. PubMed ID: 30828791
[TBL] [Abstract][Full Text] [Related]
24. Interventions for chronic palmoplantar pustulosis.
Obeid G; Do G; Kirby L; Hughes C; Sbidian E; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011628. PubMed ID: 31958161
[TBL] [Abstract][Full Text] [Related]
25. Hepatoprotective effects of Portulaca oleracea extract against CCl4-induced damage in rats.
Eidi A; Mortazavi P; Moghadam JZ; Mardani PM
Pharm Biol; 2015 Jul; 53(7):1042-51. PubMed ID: 25472695
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Short Term Topical Malva Sylvestris L. Cream in Pediatric Patients with Atopic Dermatitis: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
Meysami M; Hashempur MH; Kamalinejad M; Emtiazy M
Endocr Metab Immune Disord Drug Targets; 2021; 21(9):1673-1678. PubMed ID: 33100212
[TBL] [Abstract][Full Text] [Related]
27. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
28. Effect of dietary purslane (Portulaca oleracea L.) leaves powder on growth, immunostimulation, and protection of Nile tilapia, Oreochromis niloticus against Aeromonas hydrophila infection.
Abdel-Razek N; Awad SM; Abdel-Tawwab M
Fish Physiol Biochem; 2019 Dec; 45(6):1907-1917. PubMed ID: 31350647
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory plasma signature of chronic hand eczema: Associations with aetiological and clinical subtypes.
Quaade AS; Wang X; Sølberg JBK; McCauley BD; Thyssen JP; Becker C; Johansen JD
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1101-1111. PubMed ID: 38151335
[TBL] [Abstract][Full Text] [Related]
30. A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the ChildRen with Eczema, Antibiotic Management (CREAM) study.
Francis NA; Ridd MJ; Thomas-Jones E; Shepherd V; Butler CC; Hood K; Huang C; Addison K; Longo M; Marwick C; Wootton M; Howe R; Roberts A; Haq MI; Madhok V; Sullivan F;
Health Technol Assess; 2016 Mar; 20(19):i-xxiv, 1-84. PubMed ID: 26938214
[TBL] [Abstract][Full Text] [Related]
31. Alitretinoin for the treatment of severe chronic hand eczema.
Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
[TBL] [Abstract][Full Text] [Related]
32. The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial.
Worm M; Thyssen JP; Schliemann S; Bauer A; Shi VY; Ehst B; Tillmann S; Korn S; Resen K; Agner T
Br J Dermatol; 2022 Jul; 187(1):42-51. PubMed ID: 35084738
[TBL] [Abstract][Full Text] [Related]
33. Effects of purslane supplementation on C-reactive protein levels and biomarkers of oxidative stress as marks for metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.
Zhu Y; Huang Y; Santos HO; de Oliveira CVC; Zhou H; Tang N
Phytother Res; 2021 Oct; 35(10):5477-5486. PubMed ID: 34109686
[TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
35. The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial.
Gheflati A; Adelnia E; Nadjarzadeh A
Phytother Res; 2019 May; 33(5):1501-1509. PubMed ID: 30895694
[TBL] [Abstract][Full Text] [Related]
36. Interventions for pityriasis rosea.
Contreras-Ruiz J; Peternel S; Jiménez Gutiérrez C; Culav-Koscak I; Reveiz L; Silbermann-Reynoso ML
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684696
[TBL] [Abstract][Full Text] [Related]
37. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Compound Glycyrrhizin Capsules Combined with a Topical Corticosteroid in Adults with Chronic Eczema.
Xu W; Li Y; Ju M; Lai W; Lu X; Shi H; Shi W; Gu H; Li L
Evid Based Complement Alternat Med; 2020; 2020():6127327. PubMed ID: 32308712
[TBL] [Abstract][Full Text] [Related]
38. Interventions for chronic pruritus of unknown origin.
Andrade A; Kuah CY; Martin-Lopez JE; Chua S; Shpadaruk V; Sanclemente G; Franco JV
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013128. PubMed ID: 31981369
[TBL] [Abstract][Full Text] [Related]
39. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
